Toxicity of the topoisomerase I inhibitors

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.4, Iss.1, 2005-01, pp. : 45-53

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Toxicity of the topoisomerase II inhibitors

By Seiter Karen

Expert Opinion on Drug Safety, Vol. 4, Iss. 2, 2005-03 ,pp. : 219-234

Informa Healthcare

Access to resources Recommend Favorite

Camptothecin and Podophyllotoxin Derivatives: Inhibitors of Topoisomerase I and II – Mechanisms of Action, Pharmacokinetics and Toxicity Profile

By Hartmann Jörg T.

Drug Safety, Vol. 29, Iss. 3, 2006-01 ,pp. : 209-230

Adis International

Access to resources Recommend Favorite

Novel camptothecin derivatives as topoisomerase I inhibitors

By Basili Serena Moro Stefano

Expert Opinion on Therapeutic Patents, Vol. 19, Iss. 5, 2009-05 ,pp. : 555-574

Informa Healthcare

Access to resources Recommend Favorite

Dual Topoisomerase I / II Inhibitors in Cancer Therapy

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 3, 2003-01 ,pp. : 339-353

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting topoisomerase I: molecular mechanisms and cellular determinants of response to topoisomerase I inhibitors

By Beretta Giovanni Luca Perego Paola Zunino Franco

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 10, 2008-10 ,pp. : 1243-1256

Informa Healthcare

Access to resources Recommend Favorite